Health
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine – FiercePharma
AstraZeneca’s target window to apply for emergency use authorization of its troubled COVID-19 vaccine in the U.S. has passed. But the company still plans to seek…
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.
A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency nod in America in the first half of April.
Assuming that the approval will take place in a fast way, we hope to deliver 30 million doses instantly,…
-
Noosa News23 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General22 hours agoLive and dead animals seized from Kyneton business after investigation
-
Noosa News21 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home
-
General10 hours agoTexas opens probe into Kellogg’s health claims, dyes